In a recent randomized phase II trial, Barzolvolimab, an anti-KIT monoclonal antibody, has shown promise in reducing the severity of hives in adults with chronic spontaneous urticaria (CSU) who have not seen relief with antihistamines. The study, presented at the American Academy of Allergy, Asthma & Immunology annual meeting, demonstrated significant improvements in the 7-day
0 Comments
Donald Trump and his co-defendants are facing a civil fraud judgment that they have been ordered to pay, totaling over $464.6 million in fines and interest. In an attempt to pause the enforcement of this judgment, Trump’s attorneys have indicated that they plan to post a $100 million bond. However, this amount is only a
0 Comments
Health experts have raised concerns that children are now “suffering needlessly” due to a decrease in the number of parents opting for routine childhood vaccines. The UK Health Security Agency (UKHSA) noted that all jabs missed the 95% World Health Organisation (WHO) uptake target in England last year, with particularly low uptake in inner city
0 Comments
LG and Meta have recently announced a strategic collaboration focusing on extended reality (XR) devices and technologies. This partnership aims to combine Meta’s expertise in virtual reality (VR) and augmented reality (AR) experiences with LG’s capabilities in building mixed-reality devices. In late 2023, LG established an XR business unit within its Home Entertainment division, signaling
0 Comments
In a significant victory, Donald Trump has emerged as the winner of the Michigan Republican presidential primary, as projected by NBC News. This victory once again solidifies Trump’s position as the frontrunner in the GOP, leaving his last primary rival, former United Nations ambassador Nikki Haley, trailing behind. Despite Haley’s determination to continue campaigning through
0 Comments